Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |